Bizarre Patents
A portable partition for use in an automobile having a seat with a seat bench and a seat backrest.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178694 | Heterocyclylaminoalkyl substituted benzimidazoles Heterocyclylaminoalkyl Substituted Benzimidazoles Inhibitors of RSV replication of formula (I): The salts and stereochemically isomeric forms thereof, wherein Q is hydrogen, C1-6alkyl optionally substituted with a heterocycle or Q is C1-6alkyl substituted with both ... | 05/15/2012 |
| 8058439 | Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone The present invention is directed to processes for preparing oxycodone base and oxycodone hydrochloride compositions having less than 10 ppm of 14-hydroxycodeinone. ... | 11/15/2011 |
| 8044073 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication Aminobenzimidazoles and benzimidazoles having inhibitory activity on RSV replication and having the formula the prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms ther... | 10/25/2011 |
| 8034835 | 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs Inhibitors of RSV replication of formula (I) which can be represented by formula (I) the salts and stereochemically isomeric forms thereof, wherein R is a radical of formula | 10/11/2011 |
| 7906647 | Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone The present invention is directed to processes for preparing oxycodone base and oxycodone hydrochloride compositions having less than 10 ppm of 14-hydroxycodeinone. ... | 03/15/2011 |
| 7884186 | Isotopically labeled trapping agent and method for identifying reactive metabolites The present invention is directed to an isotopically labeled trapping agent, methods for detecting reactive metabolites and methods of identifying drug candidates. More specifically, the isotopically labeled trapping agent and methods for detecting reactive metaboli... | 02/08/2011 |
| 7875719 | Process for reducing impurities in oxycodone base The present invention is directed to a process for using n-butanol to prepare an oxycodone base compositions having reduced levels of impurities such as 14-hydroxycodeinone and DHDHC. ... | 01/25/2011 |
| 7868023 | Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions Disclosed are compounds for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade. The compounds are of Formula I or a solvate, hydrate, pharmaceutically acceptabl... | 01/11/2011 |
| 7795279 | Method of inhibiting FLT3 kinase A method of reducing or inhibiting kinase activity of FLT3 in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 using a compound of the present invention: ... | 09/14/2010 |
| 7662837 | Inhibitors of c-fms kinase The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit... | 02/16/2010 |
| 7645755 | Inhibitors of c-fms kinase The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit... | 01/12/2010 |
| 7582753 | Process for the preparation of benzotriazepine derivatives The present invention is directed to a novel process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives, useful in the preparation of gastrin and cholecystokinin receptor ligands. ... | 09/01/2009 |
| 7534888 | Oxycodone polymorphs Oxycodone.HCl polymorph forms are disclosed which are useful as analgesic agents either in combination with or as replacements for oxycodone. ... | 05/19/2009 |
| 7160559 | Controlled release galantamine composition The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions. ... | 01/09/2007 |
| 7157589 | One step process for the preparation of anticonvulsant derivatives The present invention is directed to a one-step process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein X, R1, R3, R | 01/02/2007 |
| 7109174 | Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X are disclosed. ... | 09/19/2006 |
| 6635638 | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): ##STR1## pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.... | 10/21/2003 |
| 6620819 | Anticonvulsant derivatives useful in treating psychosis The anticonvulsant derivative topiramate useful in treating dementia and/or behavioral and psychotic disturbances in dementia is disclosed.... | 09/16/2003 |
| 6492358 | ଲ-carboline derivatives useful as inhibitors of phosphodiesterase The present invention relates to novel ଲ-carboline derivatives of the general formula ##STR1## wherein all the variables are as described within the specification, useful as phosphodiesterase inhibitors. The present invention further relates to ... | 12/10/2002 |
| 6469036 | Peptidyl heterocyclic ketones useful as tryptase inhibitors The present invention relates to a series of peptidyl heterocyclic ketones which are inflammatory cell serine protease inhibitors and their compositions and methods for the prevention and treatment of a variety of immunomediated inflammatory disorders. Mo... | 10/22/2002 |
| 6441049 | Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide binding The invention is directed to a method of treating a neurodegenerative disorder in a subject in need thereof which comprises administering to the subject an amount of a compound effective to inhibit the interaction of amyloid-beta with alpha-7 nicotinic ac... | 08/27/2002 |
| 6440986 | HIV Inhibiting pyrimidine derivatives This invention concerns the use of the compounds of formula ##STR1## the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein A is CH, CR4 or N; n is 0 to 4; Q is hydrogen or --NR | 08/27/2002 |
| 6426350 | Benzothieno[3,2-c]pyridines as 댒 antagonists The present invention concerns the compounds of formula ##STR1## the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein each R1 is independently hydrogen, halogen, C1-6 a... | 07/30/2002 |
| 6395742 | 2,4-diaminopyrimidine derivatives The present invention concerns the compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein Alk is C1-6 alkanediyl or C3-6 alkenediyl; R... | 05/28/2002 |
| 6387906 | 2,4,4-trisubstituted-1,3-dioxolane antifungals The present invention concerns novel compounds of formula ##STR1## a N-oxide form, a pharmaceutically acceptable acid addition salt or a stereochemically isomeric form thereof, wherein n is zero, 1, 2 or 3; X is N or CH; each R1 independently i... | 05/14/2002 |
| 6380194 | Substituted diamino-1,3,5-triazine derivatives This invention concerns the compounds of formula ##STR1## the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 are each independently selected from hydrogen; hydroxy; ... | 04/30/2002 |
| 6365188 | Solid mixtures of cyclodextrins prepared via meltextrusion Process for preparing a solid mixture comprising one or more cyclodextrins and an insoluble active ingredient characterized in that said process comprises a melt-extrusion step, wherein the active ingredient is embedded into the cyclodextrin carrier.... | 04/02/2002 |
| 6358527 | Fast-dissolving galanthamine hydrobromide tablet The present invention is concerned with a fast-dissolving tablet for oral administration comprising as an active ingredient a therapeutically effective amount of galanthamine hydrobromide (1:1) and a pharmaceutically acceptable carrier, characterized in t... | 03/19/2002 |
| 6103725 | Alkylaminobenzothiazole and -benzoxazole derivatives The present invention concerns the compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein X is O or S; n is 2, 3, 4 or 5; R1 is hydrogen, C | 08/15/2000 |
| 6100268 | Vasoconstrictive dihydrobenzopyran derivatives The present invention is concerned with compounds of formula ##STR1## the pharmaceutically acceptable acid addition salts thereof, and the stereochemically isomeric forms thereof, wherein R1 is hydrogen or C1-6 alkyl; R2 | 08/08/2000 |
| 6075046 | Use of nebivolol as an anti-atherogenic This invention relates to the use of an ,'-iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and ... | 06/13/2000 |
| 6066651 | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders Orally-active nipecotamide glycolamide ester derivatives of formula (I): ##STR1## are disclosed as useful in treating platelet-mediated thrombotic disorders.... | 05/23/2000 |
| 6057441 | Substituted tetracyclic tetrahydrofuran derivatives This invention concerns the compounds of formula (I), ##STR1## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereoisomeric forms thereof, wherein n is zero to 6; p and q are zero to 4; r is zero to 5; R1 and R | 05/02/2000 |
| 6057325 | Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs This invention concerns the compounds of formula ##STR1## the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Alk is C1-6 alkanediyl; R1 is hydrogen, C1-6 alkyl, ary... | 05/02/2000 |
| 6054468 | 1-(1H-pyrrol-2-ylmethyl)-2-piperidone as cell migration inhibitor The present invention is concerned with the compound 1-(1H-pyrrol-2-ylmethyl)-2-piperidone for use as a medicine, in particular for use as an agent for reducing excessive directional cell migration (as in metastasis); and with pharmaceutical compositions ... | 04/25/2000 |
| 6051718 | PDE IV inhibiting 2-cyanoiminoimidazole derivatives The present invention concerns 2-cyanoiminoimidazole derivatives having the formula ##STR1## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 ea... | 04/18/2000 |
| 6037350 | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives This invention comprises the novel compounds of formula (I) ##STR1## wherein the dotted line represents an optional bond; X is oxygen or sulfur; R1 is hydrogen, C1-12 alkyl, Ar1, Ar2 C1-6 alkyl, ... | 03/14/2000 |
| 6022532 | Agent for regulating the greasiness of the skin The use of a compound having the formula ##STR1## wherein R represents methyl or ethyl, for regulating the greasiness of the skin, particular novel physical forms of said compound, cosmetic compositions comprising said agent, processes for preparing ... | 02/08/2000 |
| 5994376 | 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases The present invention describes 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating warm-blooded animals suffering from disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase IV (PDE IV), ... | 11/30/1999 |
| 5990123 | Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines The present invention is concerned with compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein .dbd.a1 --a2 .dbd.a3 | 11/23/1999 |
